Summary.
Inflammation and immune system activation seem to play an important role in the development and progression of dementia. Hyperhomocysteinemia is common in various forms of dementia, and a significant relationship was found between concentrations of homocysteine and immune activation marker neopterin. B vitamin supplementation is able to slow-down homocysteine formation in patients.
In an open-label study, effects of B vitamin supplementation (Beneuran compositum ®) on concentrations of homocysteine and neopterin were investigated in 58 patients with Alzheimer’s disease (n = 30), vascular dementia (n = 12) and mild cognitive impairment (n = 16). In all groups of patients, a significant percentage of patients presented with homocysteine concentrations >15 µmol/L and with elevated concentrations of immune activation marker neopterin. Decline of homocysteine concentrations was observed after one month of B vitamin supplementation (all p < 0.01; paired Kruskal-Wallisn-test). By contrast, neopterin concentrations remained unchanged (all p > 0.05).
B vitamin supplementation in patients with various forms of dementia did not influence neopterin concentrations, which indicates that the degree of immune activation and inflammation remained unchanged. The question remains, if lowering of homocysteine by folate supplementation alone could have any beneficial effect to modulate the course of dementia development and if longer period of supplementation would also ameliorate immune system activation status.
Similar content being viewed by others
References
Bonaa KH, Njolstad I, Ueland PM, et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (published online Mar. 12)
CJ Boushey SA Beresford GS Omenn AG Motulsky (1995) ArticleTitleA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes J Am Med Assoc 274 1049–1057 Occurrence Handle1:CAS:528:DyaK2MXptFWhuro%3D Occurrence Handle10.1001/jama.274.13.1049
IA Brouwer M van Dusseldorp CM Thomas et al. (1999) ArticleTitleLow-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial Am J Clin Nutr 69 99–104 Occurrence Handle9925130 Occurrence Handle1:CAS:528:DyaK1MXjvFSlsg%3D%3D
M Ellinson J Thomas A Patterson (2001) ArticleTitleA critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly J Hum Nutr Diet 17 371–383 Occurrence Handle10.1111/j.1365-277X.2004.00532.x
L Flicker SD Vasikaran J Thomas JM Acres P Norman K Jamrozik GJ Hankey OP Almeida (2006) ArticleTitleEfficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia Stroke 37 547–549 Occurrence Handle16373648 Occurrence Handle1:CAS:528:DC%2BD28XlvVCntA%3D%3D Occurrence Handle10.1161/01.STR.0000198815.07315.68
B Frick G Neurauter A Diez-Ruiz et al. (2003a) ArticleTitleNeopterin and oxidation products in the blood of patients with various forms of dementia Pteridines 14 88–93 Occurrence Handle1:CAS:528:DC%2BD3sXpvV2gu74%3D
B Frick K Schroecksnadel G Neurauter et al. (2003b) ArticleTitleRapid measurement of total plasma homocysteine by HPLC Clin Chim Acta 331 19–23 Occurrence Handle1:CAS:528:DC%2BD3sXis12ksL0%3D Occurrence Handle10.1016/S0009-8981(03)00076-7
B Frick K Schroecksnadel G Neurauter et al. (2004) ArticleTitleIncreasing production of homocysteine and neopterin and degradation of tryptophan with older age Clin Biochem 37 684–687 Occurrence Handle15302611 Occurrence Handle1:CAS:528:DC%2BD2cXmsVGgs70%3D Occurrence Handle10.1016/j.clinbiochem.2004.02.007
A Fuso L Seminara RA Cavallaro et al. (2005) ArticleTitleS-adenosyl-methionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production Mol Cell Neurosci 28 195–204 Occurrence Handle15607954 Occurrence Handle1:CAS:528:DC%2BD2cXhtVyrsrrM Occurrence Handle10.1016/j.mcn.2004.09.007
A Gottsater I Anwaar KF Eriksson et al. (2000) ArticleTitleHomocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects Angiology 51 489–497 Occurrence Handle10870858 Occurrence Handle1:STN:280:DC%2BD3czis1KksQ%3D%3D Occurrence Handle10.1177/000331970005100606
W Herrmann (2001) ArticleTitleThe importance of hyperhomocysteinemia as a risk factor for diseases: an overview Clin Chem Lab Med 39 666–674 Occurrence Handle11592431 Occurrence Handle1:CAS:528:DC%2BD3MXotVSrsr8%3D Occurrence Handle10.1515/CCLM.2001.110
M Hull GM Pasinetti PS Aisen (2000) ArticleTitleElevated plasma neopterin levels in Alzheimer disease Alzheimer Dis Assoc Disord 14 228–230 Occurrence Handle11186601 Occurrence Handle1:CAS:528:DC%2BD3cXovF2htrs%3D
E Joosten (2001) ArticleTitleHomocysteine, vascular dementia and Alzheimer’s disease Clin Chem Lab Med 39 717–720 Occurrence Handle11592440 Occurrence Handle1:CAS:528:DC%2BD3MXotVSrs74%3D Occurrence Handle10.1515/CCLM.2001.119
F Leblhuber J Walli E Artner-Dworzak et al. (2000) ArticleTitleHyperhomocysteinemia in dementia J Neural Transm 107 1469–1474 Occurrence Handle11458999 Occurrence Handle1:STN:280:DC%2BD3MvgslygtQ%3D%3D Occurrence Handle10.1007/s007020070010
F Leblhuber J Walli GP Tilz H Wachter D Fuchs (1998) ArticleTitleSystemische Veränderung des Immunsystems bei Patienten mit Alzheimer-Demenz Deutsch Med Wochenschr 123 787–791 Occurrence Handle1:CAS:528:DyaK1cXjvV2mtbo%3D Occurrence Handle10.1055/s-2007-1024069
E Lonn S Yusuf MJ Arnold P Sheridan J Pogue M Micks MJ McQueen J Probstfield G Fodor C Held J Genest SuffixJr InstitutionalAuthorNameHeart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006) ArticleTitleHomocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 1567–1577 Occurrence Handle16531613 Occurrence Handle1:CAS:528:DC%2BD28XjsVKgs7s%3D Occurrence Handle10.1056/NEJMoa060900
Malouf M, Grimley EJ, Areosa SA (2003) Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 4, CD004514
A McCaddon B Regland P Hudson G Davies (2002) ArticleTitleFunctional vitamin B(12) deficiency and Alzheimer disease Neurology 58 1395–1399 Occurrence Handle12011287 Occurrence Handle1:CAS:528:DC%2BD38Xktlyks70%3D
PL McGeer EG McGeer (2004) ArticleTitleInflammation and the degenerative diseases of aging Ann NY Acad Sci 1035 104–116 Occurrence Handle15681803 Occurrence Handle1:CAS:528:DC%2BD2MXivFymsLk%3D Occurrence Handle10.1196/annals.1332.007
C Murr B Widner B Wirleitner D Fuchs (2002) ArticleTitleNeopterin as a marker for immune system activation Curr Drug Metab 3 175–187 Occurrence Handle12003349 Occurrence Handle1:CAS:528:DC%2BD38XjtVOitbg%3D Occurrence Handle10.2174/1389200024605082
B Oyvind AG Semb JE Nordrehaug et al. (2004) ArticleTitleInflammatory markers CD40L, IL-6, neopterin, and CRP are not influenced by homocysteine-lowering therapy in patients with coronary artery disease Circulation 110 IssueID[Suppl 17] 311–312
RC Petersen GE Smith SC Waring RJ Ivnik EG Tangalos E Kokmen (1999) ArticleTitleMild cognitive impairment: clinical characterization and outcome Arch Neurol 56 303–308 Occurrence Handle10190820 Occurrence Handle1:STN:280:DyaK1M3gsFSqtw%3D%3D Occurrence Handle10.1001/archneur.56.3.303
K Schroecksnadel B Frick S Kaser et al. (2003a) ArticleTitleModerate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis Clin Chim Acta 338 157–164 Occurrence Handle1:CAS:528:DC%2BD3sXpt1WhtLg%3D Occurrence Handle10.1016/j.cccn.2003.09.003
K Schroecksnadel B Frick B Wirleitner et al. (2003b) ArticleTitleHomocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells Clin Exp Immunol 134 53–56 Occurrence Handle1:CAS:528:DC%2BD3sXos1Cksrc%3D Occurrence Handle10.1046/j.1365-2249.2003.02251.x
K Schroecksnadel B Frick C Winkler et al. (2003c) ArticleTitleHyperhomocysteinemia and immune activation Clin Chem Lab Med 41 1438–1443 Occurrence Handle1:CAS:528:DC%2BD3sXpsV2hsLg%3D Occurrence Handle10.1515/CCLM.2003.221
K Schroecksnadel F Leblhuber B Frick et al. (2004) ArticleTitleAssociation of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels Alzheimer Dis Assoc Disord 18 129–133 Occurrence Handle15494618 Occurrence Handle1:CAS:528:DC%2BD2cXntFSksLg%3D Occurrence Handle10.1097/01.wad.0000127443.23312.31
J Selhub PF Jacques IH Rosenberg et al. (1999) ArticleTitleSerum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations Ann Intern Med 131 331–339 Occurrence Handle10475885 Occurrence Handle1:CAS:528:DyaK1MXmt1Kqs7Y%3D
S Seshadri A Beiser J Selhub et al. (2002) ArticleTitlePlasma homocysteine as a risk factor for dementia and Alzheimer’s disease N Engl J Med 346 476–483 Occurrence Handle11844848 Occurrence Handle1:CAS:528:DC%2BD38XhtFCktrw%3D Occurrence Handle10.1056/NEJMoa011613
BR Sommer AL Hoff M Costa (2003) ArticleTitleFolic acid supplementation in dementia: a preliminary report J Geriatr Psychiatry Neurol 16 156–159 Occurrence Handle12967058 Occurrence Handle10.1177/0891988703256052
A Troen I Rosenberg (2005) ArticleTitleHomocysteine and cognitive function Semin Vasc Med 5 209–214 Occurrence Handle16047273 Occurrence Handle10.1055/s-2005-872406
C van Guldener CD Stehouwer (2001) ArticleTitleHomocysteine-lowering treatment: an overview Expert Opin Pharmacother 2 1449–1460 Occurrence Handle11585023 Occurrence Handle1:CAS:528:DC%2BD3MXmvFKlsro%3D Occurrence Handle10.1517/14656566.2.9.1449
AR White X Huang MF Jobling et al. (2001) ArticleTitleHomocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer’s-type neurodegenerative pathways J Neurochem 76 1509–1520 Occurrence Handle11238735 Occurrence Handle1:CAS:528:DC%2BD3MXhvVCjurg%3D Occurrence Handle10.1046/j.1471-4159.2001.00178.x
B Widner F Leblhuber B Frick et al. (2002) ArticleTitleModerate hyperhomocysteinaemia and immune activation in Parkinson’s disease J Neural Transm 109 1445–1452 Occurrence Handle12486485 Occurrence Handle1:CAS:528:DC%2BD38XpsFCjtb4%3D Occurrence Handle10.1007/s00702-002-0758-8
M Wolters M Hickstein A Flintermann U Tewes A Hahn (2005) ArticleTitleCognitive performance in relation to vitamin status in healthy elderly German women – the effect of 6-month multivitamin supplementation Prev Med 41 253–259 Occurrence Handle15917019 Occurrence Handle10.1016/j.ypmed.2004.11.007
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frick, B., Gruber, B., Schroecksnadel, K. et al. Homocysteine but not neopterin declines in demented patients on B vitamins. J Neural Transm 113, 1815–1819 (2006). https://doi.org/10.1007/s00702-006-0539-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-006-0539-x